facebook_pixel
ETF Strategy 15 January 2015
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
WisdomTree India Earnings Fund: Buy. Rajan Delivers Rate Cut

WisdomTree India Earnings Fund: Buy. Rajan Delivers Rate Cut

*Reserve Bank of India Governor Raghuram Rajan cut interest rates in an unscheduled review to revive growth in Asia’s third-largest economy after inflation eased. Stocks, bonds and the rupee surged * Rajan lowered the benchmark repurchase rate to 7.75 percent from 8 percent, he said in a statement today, the first reduction since May 2013. […]

FIND OUT MORE

Equity Strategy 29 December 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
DBS Bank: +37.09%. Hold Long Positions

DBS Bank: +37.09%. Hold Long Positions

* As early as 17 March 2014, we advised to Buy DBS Bank. Target: S$18.00: http://www.bluephoenixfinancials.com/equity-strategies/dbs-buy-profit-socgens-asian-private-banking-business/ * On 20 March 2014, DBS traded as low as S$15.65, below our S$15.80-S$16.20 Buy Range * On 24 Nov 2014, DBS bank traded as high as $20.02, over and above our $19.00 target price * On 4 Dec 2014, […]

FIND OUT MORE

Equity Strategy 22 December 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Gilead Sciences: Cut Remaining Long Positions

Gilead Sciences: Cut Remaining Long Positions

* * We are long Gilead Sciences at $106 and $108.50. Target: 120: http://www.bluephoenixfinancials.com/equity-strategies/gilead-sciences-add-long-positions-harvoni-provides-96-cure-rate-hep-c/ * Earlier we cut off the $106 position suffering a loss of 12.77% * We now advice to cut off the $108.50 position. At the time of this writing GILD is trading at $94.94 which will give Investors a loss of […]

FIND OUT MORE

Equity Strategy 22 December 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Gilead Sciences: Cut Long Positions Partially

Gilead Sciences: Cut Long Positions Partially

* We are long Gilead Sciences at $106 and $108.50. Target: 120: http://www.bluephoenixfinancials.com/equity-strategies/gilead-sciences-add-long-positions-harvoni-provides-96-cure-rate-hep-c/ * We advice Investors to cut out their $106 long position. At the time of this writing GILD is trading at $94.00 which would give Investors a loss of 12.77% Why have We Turned Bearish On Gilead All Of A Sudden? * […]

FIND OUT MORE